Research Spotlight: New Therapeutic Targets Focusing on Aberrant Lipid Metabolism in Alzheimer’s Disease

12 May 2021 | Wednesday | Analysis


As the global population ages and life expectancy increases, neurodegenerative disorders like Alzheimer’s disease (AD) have the potential to overwhelm the healthcare system in the near future.
Source : PerkinElmer

Source : PerkinElmer

One of the major challenges we currently face is sparse drug discovery pipelines and low clinical trial success rates due to the variability of drug efficacy in individuals. This whitepaper explores new therapeutic targets focusing on Aberrant Lipid Metabolism in Alzheimer's Disease.

 

 

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close